Arcus Biosciences, Inc.

General ticker "RCUS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B (TTM average)

Arcus Biosciences, Inc. follows the US Stock Market performance with the rate: 20.0%.

Estimated limits based on current volatility of 2.6%: low 7.77$, high 8.19$

Factors to consider:

  • Current price 18.8% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [9.96$, 20.27$]
  • 2025-12-31 to 2026-12-31 estimated range: [7.42$, 15.84$]

Financial Metrics affecting the RCUS estimates:

  • Negative: Non-GAAP EPS, $ of -3.10 <= 0.04
  • Positive: 22.52 < Shareholder equity ratio, % of 42.17 <= 43.26
  • Negative: Operating cash flow per share per price, % of -10.34 <= 1.79
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Operating income
  • Positive: Interest expense per share, $ of 0.04 <= 0.10
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: -3.20 < Investing cash flow per share, $ of -0.93

Similar symbols

Short-term RCUS quotes

2025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-226.577.588.599.510
Price $

Long-term RCUS plot with estimates

10152025Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
RCUSS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $112.00MM $117.00MM $258.00MM
Operating Expenses $392.00MM $457.00MM $588.00MM
Operating Income $-280.00MM $-340.00MM $-330.00MM
Non-Operating Income $14.00MM $39.00MM $48.00MM
Interest Expense $2.00MM $2.00MM $4.00MM
R&D Expense $288.00MM $340.00MM $448.00MM
Income(Loss) $-266.00MM $-301.00MM $-282.00MM
Taxes $1.00MM $6.00MM $1.00MM
Profit(Loss)* $-267.00MM $-307.00MM $-282.00MM
Stockholders Equity $657.00MM $462.00MM $485.00MM
Inventory $172.00MM $0.00MM $0.00MM
Assets $1,345.00MM $1,095.00MM $1,150.00MM
Operating Cash Flow $438.00MM $-306.00MM $-170.00MM
Capital expenditure $12.00MM $24.00MM $6.00MM
Investing Cash Flow $-413.00MM $194.00MM $-84.00MM
Financing Cash Flow $33.00MM $33.00MM $277.00MM
Earnings Per Share** $-3.71 $-4.15 $-3.13

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.